FULGENT GENETICS, INC. Impairment of Long-Lived Assets Held-for-use
FULGENT GENETICS, INC. (FLGT) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2022-02-28
- FULGENT GENETICS, INC. impairment of long-lived assets held-for-use for fiscal 2021 was $0.00.
- FULGENT GENETICS, INC. impairment of long-lived assets held-for-use for fiscal 2020 was $0.00.
- FULGENT GENETICS, INC. impairment of long-lived assets held-for-use for fiscal 2019 was $0.00.
- FULGENT GENETICS, INC. impairment of long-lived assets held-for-use for fiscal 2018 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-08 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-13 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-22 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-20 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |